ALG advised Medtronic on landmark $5.7bn MiniMed split-off.

ALG is pleased to have advised its long-standing client, Medtronic plc, a global leader in healthcare technology, on the separation of its Diabetes business, MiniMed Group Inc., into an independent, publicly traded company.

The transaction was structured as a split-off and represents the first transaction of its kind by an Irish incorporated company, marking a significant development in the Irish corporate landscape.  

We are delighted to have supported Medtronic and MiniMed on this innovative and important transaction and wish both businesses every success as they enter their next phase of growth.

The ALG team was led by Deirdre Geraghty (Corporate and M&A), Alan Casey (Corporate and M&A) and Amelia O’Beirne (Tax) and included Edel Daly, Grainne Roche, Andrea Hannon and Emma Hartnett.  

Date published: 16 October 2026